Chemical Structure : Dasatinib
CAS No.: 302962-49-8
Catalog No.: PC-42426Not For Human Use, Lab Use Only.
Dasatinib (BMS-354825) is a potent, orally bioavailable, dual Src/Abl kinase inhibitor with IC50 of 0.5, 0.4, 0.5 and <1 nM for Src, Lck, Yes and Bcr-Abl, respectively.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg (Free Sample) | $28 | In stock | |
50 mg | $78 | In stock | |
100 mg | $118 | In stock | |
250 mg | $168 | In stock | |
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Dasatinib (BMS-354825) is a potent, orally bioavailable, dual Src/Abl kinase inhibitor with IC50 of 0.5, 0.4, 0.5 and <1 nM for Src, Lck, Yes and Bcr-Abl, respectively.
Dasatinib (BMS-354825) exhibits two-log increased potency relative to imatinib and retains activity against 14 of 15 imatinib-resistant BCR-ABL mutants.
Dasatinib (BMS-354825) prolongs survival of mice with BCR-ABL-driven disease and inhibits proliferation of BCR-ABL-positive bone marrow progenitor cells from patients with imatinib-sensitive and imatinib-resistant CML.
M.Wt | 488.0056 | |
Formula | C22H26ClN7O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
DMSO: 35.35 mg/mL |
|
Chemical Name/SMILES |
5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]- |
1. Shah NP, et al. Science. 2004 Jul 16;305(5682):399-401.
2. Schittenhelm MM, et al. Cancer Res. 2006 Jan 1;66(1):473-81.
3. Johnson FM, et al. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6924-32.
4. Lombardo LJ, et al. J Med Chem. 2004 Dec 30;47(27):6658-61.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright